Logo image of EQUI.MI

EQUITA GROUP SPA (EQUI.MI) Stock Fundamental Analysis

BIT:EQUI - Euronext Milan - IT0005312027 - Common Stock - Currency: EUR

4.4  -0.01 (-0.23%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EQUI. EQUI was compared to 106 industry peers in the Capital Markets industry. EQUI scores excellent on profitability, but there are some minor concerns on its financial health. EQUI is not valued too expensively and it also shows a decent growth rate. Finally EQUI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year EQUI was profitable.
In the past 5 years EQUI has always been profitable.
In multiple years EQUI reported negative operating cash flow during the last 5 years.
EQUI.MI Yearly Net Income VS EBIT VS OCF VS FCFEQUI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

EQUI has a Return On Assets of 5.57%. This is in the better half of the industry: EQUI outperforms 79.25% of its industry peers.
The Return On Equity of EQUI (17.97%) is better than 82.08% of its industry peers.
EQUI has a better Return On Invested Capital (5.60%) than 77.36% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQUI is below the industry average of 8.17%.
The 3 year average ROIC (4.80%) for EQUI is below the current ROIC(5.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.57%
ROE 17.97%
ROIC 5.6%
ROA(3y)4.06%
ROA(5y)4.66%
ROE(3y)14.41%
ROE(5y)15.84%
ROIC(3y)4.8%
ROIC(5y)5.26%
EQUI.MI Yearly ROA, ROE, ROICEQUI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

EQUI has a Profit Margin of 15.58%. This is in the better half of the industry: EQUI outperforms 63.21% of its industry peers.
EQUI's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 22.28%, EQUI is doing good in the industry, outperforming 66.04% of the companies in the same industry.
In the last couple of years the Operating Margin of EQUI has remained more or less at the same level.
EQUI has a better Gross Margin (91.44%) than 87.74% of its industry peers.
In the last couple of years the Gross Margin of EQUI has remained more or less at the same level.
Industry RankSector Rank
OM 22.28%
PM (TTM) 15.58%
GM 91.44%
OM growth 3Y-8.14%
OM growth 5Y0.85%
PM growth 3Y-9.66%
PM growth 5Y1.94%
GM growth 3Y-0.41%
GM growth 5Y0.02%
EQUI.MI Yearly Profit, Operating, Gross MarginsEQUI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

EQUI has more shares outstanding than it did 1 year ago.
EQUI has more shares outstanding than it did 5 years ago.
EQUI has a better debt/assets ratio than last year.
EQUI.MI Yearly Shares OutstandingEQUI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQUI.MI Yearly Total Debt VS Total AssetsEQUI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

EQUI has an Altman-Z score of 1.77. This is a bad value and indicates that EQUI is not financially healthy and even has some risk of bankruptcy.
EQUI has a Altman-Z score of 1.77. This is in the better half of the industry: EQUI outperforms 65.09% of its industry peers.
A Debt/Equity ratio of 1.56 is on the high side and indicates that EQUI has dependencies on debt financing.
The Debt to Equity ratio of EQUI (1.56) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACCN/A
WACCN/A
EQUI.MI Yearly LT Debt VS Equity VS FCFEQUI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 217.17 indicates that EQUI has no problem at all paying its short term obligations.
The Current ratio of EQUI (217.17) is better than 98.11% of its industry peers.
EQUI has a Quick Ratio of 217.17. This indicates that EQUI is financially healthy and has no problem in meeting its short term obligations.
EQUI has a better Quick ratio (217.17) than 98.11% of its industry peers.
Industry RankSector Rank
Current Ratio 217.17
Quick Ratio 217.17
EQUI.MI Yearly Current Assets VS Current LiabilitesEQUI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

EQUI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.20%.
EQUI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.08% yearly.
The Revenue for EQUI has decreased by -10.02% in the past year. This is quite bad
EQUI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.06% yearly.
EPS 1Y (TTM)-14.2%
EPS 3Y-15.77%
EPS 5Y6.08%
EPS Q2Q%-32.1%
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-3.97%
Revenue growth 5Y6.06%
Sales Q2Q%-14.93%

3.2 Future

EQUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.65% yearly.
The Revenue is expected to grow by 6.64% on average over the next years.
EPS Next Y24.52%
EPS Next 2Y13.24%
EPS Next 3Y10.65%
EPS Next 5YN/A
Revenue Next Year10.95%
Revenue Next 2Y8.58%
Revenue Next 3Y6.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EQUI.MI Yearly Revenue VS EstimatesEQUI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
EQUI.MI Yearly EPS VS EstimatesEQUI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.58, the valuation of EQUI can be described as reasonable.
Based on the Price/Earnings ratio, EQUI is valued a bit cheaper than 76.42% of the companies in the same industry.
When comparing the Price/Earnings ratio of EQUI to the average of the S&P500 Index (24.29), we can say EQUI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 11.18, the valuation of EQUI can be described as reasonable.
79.25% of the companies in the same industry are more expensive than EQUI, based on the Price/Forward Earnings ratio.
EQUI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.58
Fwd PE 11.18
EQUI.MI Price Earnings VS Forward Price EarningsEQUI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EQUI.MI Per share dataEQUI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EQUI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.47
PEG (5Y)1.9
EPS Next 2Y13.24%
EPS Next 3Y10.65%

More info and screens

7

5. Dividend

5.1 Amount

EQUI has a Yearly Dividend Yield of 8.16%, which is a nice return.
Compared to an average industry Dividend Yield of 6.56, EQUI pays a better dividend. On top of this EQUI pays more dividend than 97.17% of the companies listed in the same industry.
EQUI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 8.16%

5.2 History

The dividend of EQUI has a limited annual growth rate of 2.88%.
Dividend Growth(5Y)2.88%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

EQUI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP0%
EPS Next 2Y13.24%
EPS Next 3Y10.65%
EQUI.MI Yearly Income VS Free CF VS DividendEQUI.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

More info and screens

EQUITA GROUP SPA

BIT:EQUI (5/7/2025, 3:29:42 PM)

4.4

-0.01 (-0.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12 2024-11-12
Earnings (Next)N/A N/A
Inst Owners7.8%
Inst Owner ChangeN/A
Ins Owners8.14%
Ins Owner ChangeN/A
Market Cap231.62M
Analysts44
Price Target4.69 (6.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.16%
Yearly Dividend0.36
Dividend Growth(5Y)2.88%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.22%
PT rev (3m)2.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.58%
EPS NY rev (3m)1.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.38%
Revenue NY rev (3m)-4.38%
Valuation
Industry RankSector Rank
PE 11.58
Fwd PE 11.18
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 2.21
P/tB 2.96
EV/EBITDA N/A
EPS(TTM)0.38
EY8.64%
EPS(NY)0.39
Fwd EY8.95%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.3
BVpS1.99
TBVpS1.49
PEG (NY)0.47
PEG (5Y)1.9
Profitability
Industry RankSector Rank
ROA 5.57%
ROE 17.97%
ROCE 7.97%
ROIC 5.6%
ROICexc 7.27%
ROICexgc 9.1%
OM 22.28%
PM (TTM) 15.58%
GM 91.44%
FCFM N/A
ROA(3y)4.06%
ROA(5y)4.66%
ROE(3y)14.41%
ROE(5y)15.84%
ROIC(3y)4.8%
ROIC(5y)5.26%
ROICexc(3y)7.15%
ROICexc(5y)7.98%
ROICexgc(3y)9.1%
ROICexgc(5y)9.9%
ROCE(3y)7%
ROCE(5y)9.5%
ROICexcg growth 3Y-26.21%
ROICexcg growth 5Y13.52%
ROICexc growth 3Y-26.66%
ROICexc growth 5Y9.79%
OM growth 3Y-8.14%
OM growth 5Y0.85%
PM growth 3Y-9.66%
PM growth 5Y1.94%
GM growth 3Y-0.41%
GM growth 5Y0.02%
F-ScoreN/A
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 217.17
Quick Ratio 217.17
Altman-Z 1.77
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.2%
EPS 3Y-15.77%
EPS 5Y6.08%
EPS Q2Q%-32.1%
EPS Next Y24.52%
EPS Next 2Y13.24%
EPS Next 3Y10.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-3.97%
Revenue growth 5Y6.06%
Sales Q2Q%-14.93%
Revenue Next Year10.95%
Revenue Next 2Y8.58%
Revenue Next 3Y6.64%
Revenue Next 5YN/A
EBIT growth 1Y-16.6%
EBIT growth 3Y-11.79%
EBIT growth 5Y6.96%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A